There are over 100 active compounds called cannabinoids in the cannabis plant. However, two major players – THC and CBD – dominate discussions about medical marijuana and hemp derivative therapies. While strictly regulated as illicit substances historically, changing attitudes and legislation continue bringing cannabinoids into mainstream health and wellness spaces.
CBD without the high
In contrast, CBD by itself does not induce any intoxicating effects. Short for cannabidiol, CBD interfaces with endocannabinoid systems in different ways from THC to modulate various physiological processes. Rather than binding directly to receptors, CBD triggers indirect actions by inhibiting enzymes that break down anandamide – an intrinsic endocannabinoid neurotransmitter that involves mood, cognition, and pain. It elevates circulating anandamide levels through a concept called the “entourage effect”. Elevated anandamide translates into wide-ranging therapeutic qualities similar to THC but without associated high or mental cloudiness. The list of conditions CBD potentially benefits includes:
- Neurodegenerative Disease
THC and the euphoric high
what is thc? Tetrahydrocannabinol (THC) makes up the psychoactive constituent abundant in marijuana strains cultivated for recreational and therapeutic use. THC fits like a lock and key into endogenous cannabinoid receptors throughout the body, activating them to alter neurochemistry, especially in the brain.
Attaching to CB1 receptors, THC stimulates the limbic system to release the pleasure neurotransmitter dopamine, triggering euphoric effects and changes in things like mood, appetite, and perception of pain. This creates the classic cannabis “high” recreational users value and seek for relaxation and enjoyment. But THC pathways extend beyond just getting stoned. Researchers also recognize THC’s potential to treat symptoms of conditions like. THC-based medicine does not come without side effects.
- Chronic Pain
- Muscle Spasms
- Poor Appetite
Analyzing safety profiles
THC activation of CB1 receptors in the brain comes from structurally mimicking natural cannabinoid neurotransmitters humans already produce endogenously. This means therapeutic applications for symptoms like chronic pain make sense when accounting for metabolic tolerance thresholds. However, direct stimulation of CB1 receptors also explains psychoactive drawbacks that limit medicinal usefulness where mental impairment remains problematic.
Full spectrum cannabis synergy
While isolated forms of CBD offer proven benefits, evidence increasingly shows other complementary cannabinoids boost therapeutic effects in what scientists call the “entourage effect”. This phenomenon demonstrates how minor hemp compounds rich in some CBD oils exponentially magnify the benefits realized by users. Terpenes constitute another class of synergistic cannabis derivatives interacting to amplify medicinal properties. Responsible for distinguishing aroma profiles across strains, terpenes modulate neurotransmitter activity by working alongside cannabinoids.
Choosing what’s right for you
When weighing therapeutic cannabinoid decisions, carefully balance intended use with individual factors like drug testing risks or personal substance sensitivities. Pure CBD alternatives allow harnessing clinical benefits without any secondary THC psychoactivity interfering with daily life functionality. However, others find micro-doses of THC taken alone or with CBD extracts more effectively manage their symptoms. This remains especially true for chronic pain patients able to tolerate mild psychoactive properties from THC alongside reduced prescription opioid requirements.